PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease ReportsNarcolepsy
MeSH D009290 - narcolepsy
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D006970:Disorders of excessive somnolence
0 Companies
0 Drugs
Success rate
D009290: 
Narcolepsy
77 Companies
14 Drugs
$
Success rate
D002385:Cataplexy
6 Companies
1 Drug
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaAmphetamine, Dextroamphetamine, Dextroamphetamine saccharate, Amphetamine dl-aspartate Adderall  1996-02-13   
Amphetamine, Dextroamphetamine, Dextroamphetamine adipate, Amphetamine adipate Delcobese  1982-01-01   
Dextroamphetamine Dexampex  1982-01-01   
Amphetamine, Dextroamphetamine, Dextroamphetamine saccharate, Amphetamine dl-aspartate Dextroamp Saccharate, Amp Aspartate, Dextroamp Amp  2003-09-30   
Methylphenidate Methylphenidate  2012-07-19   
Novast LaboratoriesAmphetamine Amphetamine  2020-08-24   
Glenmark PharmaceuticalsAmphetamine Amphetamine  2021-01-27   
CorePharmaAmphetamine, Dextroamphetamine, Dextroamphetamine saccharate, Amphetamine dl-aspartate Dextroamp Saccharate, Amp Aspartate, Dextroamp Amp  2015-11-10   
Quagen PharmaDextroamphetamine Dextroamphetamine  2016-01-27   
Methylphenidate Methylphenidate  2020-06-04   
MylanMethylphenidate Methylphenidate  2022-03-14   
NATCO PharmaModafinil Modafinil  2012-07-16   
Johnson & JohnsonMethylphenidate Concerta  2000-08-01 $612 M Q2/24-Q1/25 
GSKDextroamphetamine Dexedrine  1982-01-01   
SandozAmphetamine, Dextroamphetamine, Dextroamphetamine saccharate, Amphetamine dl-aspartate Dextroamp Saccharate, Amp Aspartate, Dextroamp Amp  2002-06-14   
Dextroamphetamine Dextroamphetamine  1982-01-01   
Methylphenidate Ritalin  1982-01-01   
1
2
3
4
5
6
...
8
>
Clinical Trials
Historical Success Rate
Phase 1
89%
8/9
Phase 2
36%
4/11
Phase 3
84%
16/19
Approved: 11Overall Success rate: 27%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Methylphenidate,
Pemoline,
Methylphenidate hydrochloride,
Carboxymethylcellulose,
Microcrystalline cellulose
Johnson & Johnson
Methylphenidate,
Methylphenidate hydrochloride
GSK
As-03,
Fluzone,
GSK189254,
Flumist,
Flucelvax
Novartis
Methylphenidate,
Methylphenidate hydrochloride
UCB
Oxybate,
Aspartame,
Endocrine
Takeda
Amphetamine,
Dextroamphetamine,
Benzocaine,
Edrecolomab,
DANAVOREXTON
1
2
3
4
5
6
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use